Loading…
Based on limited metadata available, Imprimis NJOF, LLC, a pharmaceutical company, received an FDA Warning Letter on June 7, 2019, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the metadata provided. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the available information.